Background: The allergenic potential of chicken egg white ovomucoid (OVM) is thought to depend on its stability to heat treatment and digestion. Pepsin-digested fragments have been speculated to continue to exert an allergenic potential. OVM was digested in simulated gastric fluid (SGF) to examine the reactivity of the resulting fragments to IgE in sera from allergic patients. Methods: OVM was digested in SGF and subjected to SDS-PAGE. The detected fragments were then subjected to N-terminal sequencing and liquid chromatography/mass spectrometry/mass spectrometry analysis to confirm the cleavage sites and partial amino acid sequences. The reactivity of the fragments to IgE antibodies in serum samples from patients allergic to egg white was then determined using Western blotting (n = 24). Results: The rate of OVM digestion depended on the pepsin/OVM ratio in the SGF. OVM was first cleaved near the end of the first domain, and the resulting fragments were then further digested into smaller fragments. In the Western blot analysis, 93% of the OVM-reactive sera also bound to the 23.5- to 28.5-kDa fragments, and 21% reacted with the smaller 7- and 4.5-kDa fragments. Conclusion: When the digestion of OVM in SGF was kinetically analyzed, 21% of the examined patients retained their IgE-binding capacity to the small 4.5-kDa fragment. Patients with a positive reaction to this small peptide fragment were thought to be unlikely to outgrow their egg white allergy. The combination of SGF-digestibility studies and human IgE-binding experiments seems to be useful for the elucidation and diagnosis of the allergenic potential of OVM.

1.
Sampson HA, McCaskill CC: Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients. J Pediatr 1985;107:669–675.
2.
Bock SA, Sampson HA, Atkins FM, Zeiger RS, Lehrer S, Sachs M, Bush RK, Metcalfe DD: Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual. J Allergy Clin Immunol 1988;82:986–997.
3.
Bock SA, Atkins FM: Patterns of food hypersensitivity during sixteen years of double-blind, placebo-controlled food challenges. J Pediatr 1990;117:561–567.
4.
Boyano-Martinez T, Garcia-Ara C, Diaz-Pena JM, Martin-Esteban M: Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol 2002;110:304–309.
5.
Kotaniemi-Syrjanen A, Reijonen TM, Romppanen J, Korhonen K, Savolainen K, Korppi M: Allergen-specific immunoglobulin E antibodies in wheezing infants: The risk for asthma in later childhood. Pediatrics 2003;111:e255–e261.
6.
Li-Chan E, Nakai S: Biochemical basis for the properties of egg white. Crit Rev Poultry Biol 1989;2:21–58.
7.
Kato I, Schrode J, William J. Kohr WJ, Laskowski M Jr: Chicken ovomucoid: Determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains. Biochemistry 1987;26:193–201.
8.
Matsuda T, Watanabe K, Nakamura R: Immunochemical and physical properties of peptic-digested ovomucoid. J Agric Food Chem 1983;31:942–946.
9.
Honma K, Aoyagi M, Saito K, Nishimuta T, Sugimoto K, Tsunoo H, Niimi H, Kohno Y: Antigenic determinants on ovalbumin and ovomucoid: Comparison of the specificity of IgG and IgE antibodies. Arerugi 1991;40:1167–1175.
10.
Takagi K, Teshima R, Okunuki H, Sawada J: Comparative study of in vitro digestibility of food proteins and effect of preheating on the digestion. Biol Pharm Bull 2003;26:969–973.
11.
Fu TJ, Abbott UR, Hatzos C: Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid-a comparative study. J Agric Food Chem 2002;50:7154–7160.
12.
Zhang JW, Mine Y: Characterization of IgE and IgG epitopes on ovomucoid using egg-white-allergic patients’ sera. Biochem Biophys Res Commun 1998;253:124–127.
13.
Matsuda T, Nakamura R, Nakashima I, Hasegawa Y, Shimokata K: Human IgE antibody to the carbohydrate-containing third domain of chicken ovomucoid. Biochem Biophys Res Commun 1985;129:505–510.
14.
Thomas K, Aalbers M, Bannon GA, Bartels M, Dearman RJ, Esdaile DJ, Fu TJ, Glatt CM, Hadfield N, Hatzos C, Hefle SL, Heylings JR, Goodman RE, Henry B, Herouet C, Holsapple M, Ladics GS, Landry TD, MacIntosh SC, Rice EA, Privalle LS, Steiner HY, Teshima R, Van Ree R, Woolhiser M, Zawodny J: A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins. Regul Toxicol Pharmacol 2004;39:87–98.
15.
Kovacs-Nolan J, Zhang JW, Hayakawa S, Mine Y: Immunochemical and structural analysis of pepsin-digested egg white ovomucoid. J Agric Food Chem 2000;48:6261–6266.
16.
Besler M, Petersen A, Steinhart H, Paschke A: Identification of IgE-Binding Peptides Derived from Chemical and Enzymatic Cleavage of Ovomucoid (Gal d 1). Internet Symposium on Food Allergens 1999;1:1–12. http://www.food-allergens.de
17.
Urisu A, Yamada K, Tokuda R, Ando H, Wada E, Kondo Y, Morita Y: Clinical significance of IgE-binding activity to enzymatic digests of ovomucoid in the diagnosis and the prediction of the outgrowing of egg white hypersensitivity. Int Arch Allergy Immunol 1999;120:192–198.
18.
Zacharius RM, Zell TE, Morrison JH, Woodlock JJ: Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem 1969;30:148–152.
19.
Mine Y, Zhang JW: Identification and fine mapping of IgG and IgE epitopes in ovomucoid. Biochem Biophys Res Commun 2002;292:1070–1074.
20.
Beyer K, Ellman-Grunther L, Jarvinen KM, Wood RA, Hourihane J, Sampson HA: Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol 2003;112:202–207.
21.
Mine Y, Sasaki E, Zhang JW: Reduction of antigenicity and allergenicity of genetically modified egg white allergen, ovomucoid third domain. Biochem Biophys Res Commun 2003;302:133–137.
22.
Matsuda T, Gu J, Tsuruta K, Nakamura R: Immunoreactive glycopeptides separated from peptic hydrolysate of chicken egg white ovomucoid. J Food Sci 1985;50:592–594.
23.
Cooke SK, Sampson HA: Allergenic properties of ovomucoid in man. J Immunol 1997;159:2026–2032.
24.
Kane PM, Holowka D, Baird B: Cross-linking of IgE receptor complexes by rigid bivalent antigens greater than 200 Aring; in length triggers cellular degranulation. J Cell Biol 1988;107:969–980.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.